Novel diarylalkanoids having activity as lipoxygenase inhibitors
申请人:WARNER-LAMBERT COMPANY
公开号:EP0241043A2
公开(公告)日:1987-10-14
The present invention is novel diarylalkanoids having activity as lipoxygenase inhibitors, novel pharmaceutical compositions therefor, and novel methods of use in treating asthma, allergies, cardiovascular diseases, migraines, psoriasis and immunoinflammatory diseases for diarylalkanoids. The compounds of this invention are also useful as cytoprotective agents.
Diarylheptanoide derivative and pharmaceutical composition comprising the same
申请人:KABUSHIKI KAISHA YAKULT HONSHA
公开号:EP0717027A1
公开(公告)日:1996-06-19
A diarylheptanoide derivative of the following formula (1),
and a drug composition comprising this compound, such as a 5-lipoxygenase inhibitor, an antiinflammatory agent, and the like. The diarylheptanoide derivative (1) is effective for treating and preventing various inflammatory diseases due to its strong 5-lipoxygenase inhibiting effect.
Synthesis and neuroprotective effect of E-3,4-dihydroxy styryl aralkyl ketones derivatives against oxidative stress and inflammation
作者:Xianling Ning、Ying Guo、Xiaoyan Ma、Renzong Zhu、Chao Tian、Xiaowei Wang、Zhizhong Ma、Zhili Zhang、Junyi Liu
DOI:10.1016/j.bmcl.2013.05.016
日期:2013.7
E-3,4-Dihydroxy styryl aralkyl ketones as well as their 3,4-diacetylated derivatives as the analogues of neuroprotective agent CAPE were designed and synthesized for improving stability and lipid solubility. The neuroprotective activities of target compounds 10a-g and 11a-g were tested by three models in vitro, including 1,1-diphenyl-2-picrylhydrazyl radical scavenging capacity, neuronal protecting effect against damage induced by H2O2 in PC12 cells and nitric oxide suppression effect in BV2 microglial cells. The results demonstrated that compounds 10f and 11f exhibited the most potent neuroprotective effect against oxidative stress and inflammation, which is higher than that of the lead compound CAPE. (C) 2013 Elsevier Ltd. All rights reserved.